K63-Ubiquitin-mediated cell signal regulation in epidermis
K63-泛素介导的表皮细胞信号调节
基本信息
- 批准号:10596571
- 负责人:
- 金额:$ 35.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AcneAndrogen ReceptorAndrogensAnimal ModelApoptosisBenignCellsChemicalsClinicClustered Regularly Interspaced Short Palindromic RepeatsCoenzyme ACoenzymesCrohn&aposs diseaseDNA RepairDataDefectDiseaseDisease modelDominant Genetic ConditionsEnzymesEpidermisEpithelial CellsGene ExpressionGene Expression RegulationGene TargetingGenesGeneticGenetic DiseasesGoalsGrowthHairHair follicle structureHandHealthHomeostasisHumanHyperplasiaImmune System DiseasesInfertilityInflammationInflammatoryLinkMalignant NeoplasmsMass Spectrum AnalysisMediatingMediatorMethodsModelingMolecularMorphogenesisMusMutant Strains MiceNatureNuclearOncogenesOutcomePathogenesisPathogenicityPathologicPathway interactionsPatientsPeptide HydrolasesPhenotypePlayPost-Translational Protein ProcessingProcessProliferatingProteinsProteomicsProtocols documentationPsoriasisReceptor InhibitionRecurrenceRegulationRegulator GenesRoleSHH geneSebaceous GlandsSebaceous adenomaSignal TransductionSiteSkinSkin CancerSkin CarcinogenesisSkin TissueSyndromeTechnologyTherapeuticTissue ModelTissuesTranscription Factor AP-1Transduction GeneTranslationsTumor SuppressionUbiquitinUbiquitin-Conjugating EnzymesUbiquitinationWorkappendagec-myc Genesclinical effectclinical translationclinically relevantcofactordesigndimethylbenzanthraceneepidermal stem cellhuman diseaseimmune functioninhibitorinsightkeratinocyteloss of functionmale fertilitymouse modelmutantneoplasticnovelpharmacologicreceptor expressionskin barrierskin disorderskin regenerationsmall hairpin RNAstem cell differentiationstem cellstargeted treatmenttherapy developmenttranscription factortranscriptometumortumor growthtumorigenesisubiquitin isopeptidase
项目摘要
ABSTRACT
Epidermis and its appendages constitute the outermost skin barrier essential for mammalian health and
survival. Dysregulation of cell signaling in epidermal cells involving NF-κB, AP1, and c-Myc gene regulators
can lead to local and systemic disorders, as well as cancer. Nevertheless, direct targeting of these core
transcription factors has been proven technically challenging, prohibiting a meaningful clinical translation. Our
long-term objective is to explore how K63-Ubiquitin (K63-Ub)-mediated signals converge on gene regulation
and can be rationally targeted for therapy of inflammatory and neoplastic skin disorders. Towards this end, our
recent efforts are focused on characterizing novel functions of CYLD, a K63-Ub protease whose loss-of-
function is linked to immunological diseases, infertility, and benign and malignant neoplasms. While mutant
Cyld in humans leads to Cyldm-syndrome characterized by widespread and recurrent epidermal and
appendage tumors, understanding the complete role of CYLD is hampered by the lack of a clinically relevant
disease model. To uncover novel disease mechanisms we have generated a mouse model that recapitulates
genetic and phenotypic features of human Cyldm-syndrome. Using this animal model, we have identified c-Myc
as a new CYLD substrate, UBE2N as an upstream regulator of c-Myc and androgen signaling, in addition to a
role of CYLD in the regulation of the NF-κB and AP1 pathways. These findings highlight the broad impact of
CYLD and the utility of the Cyldm skin model for increasing our understanding of novel disease mechanisms.
This study is designed based on the hypothesis that unopposed UBE2N function in epithelial cells
promotes inflammation and c-Myc-dependent skin defects. We propose three specific aims: 1) to define
the role of c-Myc in Cyldm skin; 2) to determine the molecular mechanisms underlying K63-Ub-mediated c-Myc
activation; and 3) to determine the functions of UBE2N in epidermal proliferation and tumorigenesis. We will
utilize mouse and human skin tissue models, as well as cutting-edge technologies for gene editing,
transcriptome and protein interactome analyses. Completion of these studies will reveal novel molecular
mechanisms of epidermal morphogenesis and provide therapeutic insights for skin inflammation and cancer.
摘要
表皮及其附属物构成哺乳动物健康所必需的最外层皮肤屏障,
生存表皮细胞中涉及NF-κB、AP 1和c-Myc基因调控因子的细胞信号转导失调
会导致局部和全身性疾病以及癌症。然而,直接针对这些核心
转录因子已经被证明在技术上具有挑战性,禁止有意义的临床翻译。我们
长期目标是探索K63-Ub介导的信号如何汇聚于基因调控
并且可以合理地靶向治疗炎性和肿瘤性皮肤病。为此,我们
最近的努力集中在表征CYLD的新功能上,CYLD是一种K63-Ub蛋白酶,
这种功能与免疫性疾病、不育症以及良性和恶性肿瘤有关。虽然突变
人类的Cyld导致Cyld综合征,其特征在于广泛和复发的表皮和
附件肿瘤,了解CYLD的完整作用是由于缺乏临床相关的
疾病模型。为了揭示新的疾病机制,我们建立了一个小鼠模型,
人Cyldm综合征的遗传和表型特征。使用这种动物模型,我们已经鉴定了c-Myc
作为一种新的CYLD底物,UBE 2N作为c-Myc和雄激素信号传导的上游调节剂,除了作为一种新的CYLD底物外,
CYLD在NF-κB和AP 1通路调节中的作用。这些发现突出了
CYLD和Cyldm皮肤模型的实用性,以增加我们对新疾病机制的理解。
这项研究是基于这样的假设设计的,即在上皮细胞中无对抗的UBE 2N功能
促进炎症和c-Myc依赖性皮肤缺陷。我们提出了三个具体目标:1)定义
c-Myc在Cyldm皮肤中的作用; 2)确定K63-Ub介导c-Myc的分子机制
3)确定UBE 2N在表皮增殖和肿瘤发生中的功能。我们将
利用小鼠和人类皮肤组织模型,以及基因编辑的尖端技术,
转录组和蛋白质相互作用组分析。这些研究的完成将揭示新的分子
表皮形态发生的机制,并提供治疗皮肤炎症和癌症的见解。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
An aging-susceptible circadian rhythm controls cutaneous antiviral immunity.
衰老的昼夜节律控制皮肤抗病毒免疫。
- DOI:10.1172/jci.insight.171548
- 发表时间:2023-10-23
- 期刊:
- 影响因子:8
- 作者:Kirchner, Stephen J.;Lei, Vivian;Kim, Paul T.;Patel, Meera;Shannon, Jessica L.;Corcoran, David;Hughes, Dalton;Waters, Diana K.;Dzirasa, Kafui;Erdmann, Detlev;Coers, Jorn;MacLeod, Amanda S.;Zhang, Jennifer Y.
- 通讯作者:Zhang, Jennifer Y.
Human Skin Explant Preparation and Culture.
人类皮肤外植体的制备和培养。
- DOI:10.21769/bioprotoc.4514
- 发表时间:2022
- 期刊:
- 影响因子:0.8
- 作者:Shannon,JessicaL;Kirchner,StephenJ;Zhang,JenniferY
- 通讯作者:Zhang,JenniferY
Thymic stromal lymphopoietin controls hair growth.
- DOI:10.1016/j.stemcr.2022.01.017
- 发表时间:2022-03-08
- 期刊:
- 影响因子:5.9
- 作者:Shannon, Jessica L.;Corcoran, David L.;Murray, John C.;Ziegler, Steven F.;MacLeod, Amanda S.;Zhang, Jennifer Y.
- 通讯作者:Zhang, Jennifer Y.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jennifer Yunyan Zhang其他文献
Jennifer Yunyan Zhang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jennifer Yunyan Zhang', 18)}}的其他基金
K63-Ubiquitin-mediated cell signal regulation in epidermis
K63-泛素介导的表皮细胞信号调节
- 批准号:
10379315 - 财政年份:2019
- 资助金额:
$ 35.42万 - 项目类别:
K63-Ubiquitin-mediated cell signal regulation in epidermis
K63-泛素介导的表皮细胞信号调节
- 批准号:
9903230 - 财政年份:2019
- 资助金额:
$ 35.42万 - 项目类别:
Dynamic Control of Innate Antiviral Immunity in Skin Homeostasis and Inflammation
皮肤稳态和炎症中先天抗病毒免疫的动态控制
- 批准号:
9924441 - 财政年份:2018
- 资助金额:
$ 35.42万 - 项目类别:
Dynamic Control of Innate Antiviral Immunity in Skin Homeostasis and Inflammation
皮肤稳态和炎症中先天抗病毒免疫的动态控制
- 批准号:
10397558 - 财政年份:2018
- 资助金额:
$ 35.42万 - 项目类别:
Dynamic Control of Innate Antiviral Immunity in Skin Homeostasis and Inflammation
皮肤稳态和炎症中先天抗病毒免疫的动态控制
- 批准号:
10686699 - 财政年份:2018
- 资助金额:
$ 35.42万 - 项目类别:
THE ROLE OF MALT1 IN MELANOMA GROWTH AND METASTASIS
Malt1 在黑色素瘤生长和转移中的作用
- 批准号:
9102022 - 财政年份:2015
- 资助金额:
$ 35.42万 - 项目类别:
JUN PROTEINS IN EPIDERMAL HOMEOSTASIS AND NEOPLASIA
Jun 蛋白在表皮稳态和肿瘤形成中的作用
- 批准号:
8131846 - 财政年份:2010
- 资助金额:
$ 35.42万 - 项目类别:
JUN PROTEINS IN EPIDERMAL HOMEOSTASIS AND NEOPLASIA
Jun 蛋白在表皮稳态和肿瘤形成中的作用
- 批准号:
8664734 - 财政年份:2010
- 资助金额:
$ 35.42万 - 项目类别:
JUN PROTEINS IN EPIDERMAL HOMEOSTASIS AND NEOPLASIA
Jun 蛋白在表皮稳态和肿瘤形成中的作用
- 批准号:
8272464 - 财政年份:2010
- 资助金额:
$ 35.42万 - 项目类别:
JUN PROTEINS IN EPIDERMAL HOMEOSTASIS AND NEOPLASIA
Jun 蛋白在表皮稳态和肿瘤形成中的作用
- 批准号:
7898983 - 财政年份:2010
- 资助金额:
$ 35.42万 - 项目类别:
相似海外基金
Androgen receptor: A master regulator of lipid metabolism
雄激素受体:脂质代谢的主要调节因子
- 批准号:
DP230103210 - 财政年份:2023
- 资助金额:
$ 35.42万 - 项目类别:
Discovery Projects
Regulation of androgen receptor signaling in prostate cancer by protein arginine methylation
通过蛋白质精氨酸甲基化调节前列腺癌中的雄激素受体信号传导
- 批准号:
10584689 - 财政年份:2023
- 资助金额:
$ 35.42万 - 项目类别:
Structural and functional analysis of a novel class of androgen receptor antagonists
一类新型雄激素受体拮抗剂的结构和功能分析
- 批准号:
10650956 - 财政年份:2023
- 资助金额:
$ 35.42万 - 项目类别:
Role of the Androgen Receptor in Insulin Secretion in the Male
雄激素受体在男性胰岛素分泌中的作用
- 批准号:
10488954 - 财政年份:2023
- 资助金额:
$ 35.42万 - 项目类别:
Targeting tumor cell macrophage lipid interactions to overcome resistance to androgen receptor targeted therapy
靶向肿瘤细胞巨噬细胞脂质相互作用以克服对雄激素受体靶向治疗的耐药性
- 批准号:
10651105 - 财政年份:2023
- 资助金额:
$ 35.42万 - 项目类别:
Preclinical development of ONCT-505, an Androgen Receptor Antagonist and Degrader, as new potential therapeutic for Kennedy's Disease
ONCT-505(一种雄激素受体拮抗剂和降解剂)的临床前开发,作为肯尼迪病的新潜在治疗方法
- 批准号:
10603636 - 财政年份:2023
- 资助金额:
$ 35.42万 - 项目类别:
Proliferating cell nuclear antigen in regulation of androgen receptor signalings in castration-resistant prostate cancer cells
增殖细胞核抗原对去势抵抗性前列腺癌细胞雄激素受体信号传导的调节
- 批准号:
10544062 - 财政年份:2022
- 资助金额:
$ 35.42万 - 项目类别:
Effects of androgen receptor (AR) signaling on CD4+ T cell metabolism during airway inflammation
气道炎症期间雄激素受体 (AR) 信号对 CD4 T 细胞代谢的影响
- 批准号:
10534943 - 财政年份:2022
- 资助金额:
$ 35.42万 - 项目类别:
TITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE
标题:使用雄激素受体抑制剂阿帕鲁胺进行膀胱癌化学预防
- 批准号:
10677989 - 财政年份:2022
- 资助金额:
$ 35.42万 - 项目类别:














{{item.name}}会员




